Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno G Reigner

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Pharmacology|April 9, 2002
Estimating the starting dose for entry into humans: principles and practiceBruno G Reigner, Karen Smith Blesch
Investigational New Drugs|August 2, 2003
Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experienceKaren S Blesch, Ronald Gieschke, Yuko Tsukamoto, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|April 9, 2002
Estimating the starting dose for entry into humans: principles and practiceBruno G Reigner, Karen Smith Blesch
Investigational New Drugs|August 2, 2003
Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experienceKaren S Blesch, Ronald Gieschke, Yuko Tsukamoto, et al.
Pageof 1